159 related articles for article (PubMed ID: 32520641)
1. Re: "Exosomes Derived from Bone Marrow Mesenchymal Stem Cells as Treatment for Severe COVID-19" by Sengupta et al.
Lim SK; Giebel B; Weiss DJ; Witwer KW; Rohde E
Stem Cells Dev; 2020 Jul; 29(14):877-878. PubMed ID: 32520641
[No Abstract] [Full Text] [Related]
2. Response to Lim et al. re: "Exosomes Derived from Bone Marrow Mesenchymal Stem Cells as Treatment for Severe COVID-19".
Sengupta V; Sengupta S; Lazo A; Hicok KC; Moseley T
Stem Cells Dev; 2020 Jul; 29(14):879-881. PubMed ID: 32520639
[No Abstract] [Full Text] [Related]
3. Immunomodulatory effect of mesenchymal stem cells and mesenchymal stem-cell-derived exosomes for COVID-19 treatment.
Jayaramayya K; Mahalaxmi I; Subramaniam MD; Raj N; Dayem AA; Lim KM; Kim SJ; An JY; Lee Y; Choi Y; Raj A; Cho SG; Vellingiri B
BMB Rep; 2020 Aug; 53(8):400-412. PubMed ID: 32731913
[TBL] [Abstract][Full Text] [Related]
4. Potential application of mesenchymal stem cells and their exosomes in lung injury: an emerging therapeutic option for COVID-19 patients.
Al-Khawaga S; Abdelalim EM
Stem Cell Res Ther; 2020 Oct; 11(1):437. PubMed ID: 33059757
[TBL] [Abstract][Full Text] [Related]
5. Potential therapeutic application of mesenchymal stem cell-derived exosomes in SARS-CoV-2 pneumonia.
Akbari A; Rezaie J
Stem Cell Res Ther; 2020 Aug; 11(1):356. PubMed ID: 32795359
[TBL] [Abstract][Full Text] [Related]
6. COVID-19 and Mesenchymal Stem Cell Treatment; Mystery or Not.
Akkoc T
Adv Exp Med Biol; 2020; 1298():167-176. PubMed ID: 32648245
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal stem cells as a potential treatment for critically ill patients with coronavirus disease 2019.
Ji F; Li L; Li Z; Jin Y; Liu W
Stem Cells Transl Med; 2020 Jul; 9(7):813-814. PubMed ID: 32320535
[No Abstract] [Full Text] [Related]
8. Mesenchymal stem cell therapy in severe COVID-19: A retrospective study of short-term treatment efficacy and side effects.
Chen X; Shan Y; Wen Y; Sun J; Du H
J Infect; 2020 Oct; 81(4):647-679. PubMed ID: 32422152
[No Abstract] [Full Text] [Related]
9. Rationale for the Use of Radiation-Activated Mesenchymal Stromal/Stem Cells in Acute Respiratory Distress Syndrome.
Tovar I; Guerrero R; López-Peñalver JJ; Expósito J; Ruiz de Almodóvar JM
Cells; 2020 Sep; 9(9):. PubMed ID: 32887260
[TBL] [Abstract][Full Text] [Related]
10. Exosomes Derived from Bone Marrow Mesenchymal Stem Cells as Treatment for Severe COVID-19.
Sengupta V; Sengupta S; Lazo A; Woods P; Nolan A; Bremer N
Stem Cells Dev; 2020 Jun; 29(12):747-754. PubMed ID: 32380908
[TBL] [Abstract][Full Text] [Related]
11. Re: "Maxillofacial Trauma Management During COVID-19: Multidisciplinary Recommendations," by Edwards et al. and "A Guide to Facial Trauma Triage and Precautions in the COVID-19 Pandemic" by Hsieh et al.
Elmaraghi S; Rao VK; Mount DL
Facial Plast Surg Aesthet Med; 2020; 22(4):313-314. PubMed ID: 32525711
[No Abstract] [Full Text] [Related]
12. [Mesenchymal stem cells in therapy of coronavirus disease 2019 - a review].
Shi X; Yu L; Ding C
Sheng Wu Gong Cheng Xue Bao; 2020 Oct; 36(10):1979-1991. PubMed ID: 33169564
[TBL] [Abstract][Full Text] [Related]
13. Response to Elmaraghi et al. re: "Maxillofacial Trauma Management During COVID-19: Multidisciplinary Recommendations".
McKean E
Facial Plast Surg Aesthet Med; 2020; 22(4):314. PubMed ID: 32525716
[No Abstract] [Full Text] [Related]
14. [Mesenchymal stem cells in the treatment of COVID-19-progress and challenges].
Wang J; Zou W; Liu J
Sheng Wu Gong Cheng Xue Bao; 2020 Oct; 36(10):1970-1978. PubMed ID: 33169563
[TBL] [Abstract][Full Text] [Related]
15. Response to Elmaraghi et al. re: "A Guide to Facial Trauma Triage and Precautions in the COVID-19 Pandemic".
Hsieh TY; Chiao W; Hilger PA
Facial Plast Surg Aesthet Med; 2020; 22(4):314. PubMed ID: 32525710
[No Abstract] [Full Text] [Related]
16. Response to Smith et al.: Telehealth for global emergencies: Implications for coronavirus disease 2019 (COVID-19).
Scott RE; Mars M
J Telemed Telecare; 2020 Jul; 26(6):378-380. PubMed ID: 32525438
[No Abstract] [Full Text] [Related]
17. Re: Jan-Niclas Mumm, Andreas Osterman, Michael Ruzicka, et al. Urinary Frequency as a Possible Overlooked Symptom in COVID-19 Patients: Does SARS-CoV-2 Cause Viral Cystitis? Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.05.013: Severe Involvement of the Urinary Tract During COVID-19 Infection.
Luciani LG; Gallo F; Malossini G
Eur Urol; 2020 Sep; 78(3):e129-e130. PubMed ID: 32591102
[No Abstract] [Full Text] [Related]
18. Re: Urinary Frequency as a Possibly Overlooked Symptom in COVID-19 Patients: Does SARS-CoV-2 Cause Viral Cystitis?
Kaplan SA
J Urol; 2020 Nov; 204(5):1071-1072. PubMed ID: 32924740
[No Abstract] [Full Text] [Related]
19. Response by Khosravani et al to Letter Regarding Article, "Protected Code Stroke: Hyperacute Stroke Management During the Coronavirus Disease 2019 (COVID-19) Pandemic".
Khosravani H; Rajendram P; Menon BK
Stroke; 2020 Aug; 51(8):e156-e157. PubMed ID: 32716831
[No Abstract] [Full Text] [Related]
20. [Analysis of coronavirus disease-19 (COVID-19) based on SARS autopsy].
Ding YQ; Bian XW
Zhonghua Bing Li Xue Za Zhi; 2020 Apr; 49(4):291-293. PubMed ID: 32268662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
